GILD
Gilead Sciences, Inc.
- Diluted EPS, 2025
- $6.78
- YoY, 2025
- +1,684.2%
- 5-year CAGR
- +132.4%
- 10-year CAGR
- −5.5%
Diluted EPS
Diluted EPS by fiscal year
| Period | EPS | YoY |
|---|---|---|
| 2025 | $6.78 | +1,684.2% |
| 2024 | $0.38 | −91.6% |
| 2023 | $4.50 | +23.6% |
| 2022 | $3.64 | −26.2% |
| 2021 | $4.93 | +4,830.0% |
| 2020 | $0.10 | −97.6% |
| 2019 | $4.22 | +1.2% |
| 2018 | $4.17 | +18.8% |
| 2017 | $3.51 | −64.7% |
| 2016 | $9.94 | −16.5% |
| 2015 | $11.91 | +62.0% |
| 2014 | $7.35 | +306.1% |
| 2013 | $1.81 | +10.4% |
| 2012 | $1.64 | −7.3% |
| 2011 | $1.77 | +6.6% |
| 2010 | $1.66 | +17.7% |
| 2009 | $1.41 | +36.9% |
| 2008 | $1.03 | +25.6% |
| 2007 | $0.82 | — |